_venetoclax-obinutuzumab-impact-on-cll-management-preview-1.jpg "Venetoclax + Obinutuzumab: Impact on CLL Management from obinutuzumab and venetoclax in cll Video Screenshot Preview 1")
Gallery_venetoclax-obinutuzumab-impact-on-cll-management-preview-3.jpg "Venetoclax + Obinutuzumab: Impact on CLL Management from obinutuzumab and venetoclax in cll Video Screenshot Preview 3")
Gallery_venetoclax-obinutuzumab-impact-on-cll-management-preview-hqdefault.jpg "Venetoclax + Obinutuzumab: Impact on CLL Management from obinutuzumab and venetoclax in cll Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 7 minutes 29 seconds
👁 View: 2.4K times
Play Audio:👁 View: 2.4K times
Description:
OncLiveTV
OncLiveTV
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_reveng-venetoclax-and-obinutuzumab-in-cll.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_venetoclax-and-obinutuzumab-for-cll.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_cll14-venetoclax-plus-obinutuzumab-in-untreated-cll.webp "Dr Othman Al-Sawaf speaks to ecancer about the four-year follow-up of the CLL14 trial looking at venetoclax and obinutuzumab in untreated chronic lymphocyte leukaemia. nnDr Al Sawaf explains that venetoclax plus obinutuzumab has been established as a fixed-duration treatment regimen for patients with chronic lymphocytic leukaemia. In the CLL14 trial, the long-term efficacy after treatment cessation of the combination of venetoclax plus obinutuzumab with chlorambucil plus obinutuzumab was compare")
_six-year-update-from-cll14-fixed-duration-venetoclax-obinutuzumab-for-previously-untreated-cll.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
⏲ 1 minute 43 seconds 👁 88
_reveng-venetoclax-and-obinutuzumab-in-cll.jpg)
_venetoclax-and-obinutuzumab-for-cll.jpg)
_cll14-venetoclax-plus-obinutuzumab-in-untreated-cll.jpg)
_six-year-update-from-cll14-fixed-duration-venetoclax-obinutuzumab-for-previously-untreated-cll.jpg)
![[+]](/images/menu.gif){kind=small}